Quest Diagnostics Incorporated Financials

Market Capitalization $19.71 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	22.33
Forward PE	18.09
Price to Sales TTM	$1.94
Price to Book MRQ	$2.85
Enterprise to Revenue	2.61
Enterprise to EBITDA	13.45

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	8.83%
Operating Margin	13.88%
Return on Assets TTM	6.13%
Return on Equity TTM	13.95%

Income Statement

Revenue TTM	$10,158,000,128
Revenue per Share TTM	$91.51
Quarterly Revenue Growth	12.10%
Gross Profit TTM	$3,356,000,000
EBITDA	$1,951,000,000
Net Income to Common TTM	$892,000,000
Diluted EPS TTM	$7.91
Quarterly Earnings Growth YoY	13.40%

Balance Sheet

Total Cash MRQ	$188,000,000
Total Cash per Share MRQ	$1.68
Total Debt MRQ	$
Total Debt to Equity MRQ	93.37
Current Ratio MRQ	1.44
Book Value per Share MRQ	$61.87

Cash Flow

Operating Cash Flow TTM	$1,494,000,000
Levered Free Cash Flow TTM	$817,625,024

DGX Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	110,615,181
Float Shares	111,063,898
Avg 10 Volume	897,100
Avg 30 Volume	None
Shares Short	3,639,500
Short Ratio	3.57
Short % of Shares	3.72%
% Held by Insiders	0.40%
% Held by Institutions	96.03%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	$136.99
Fifty Two Week High	$182.38
Fifty Two Week Change	20.61%
Day 50 MA	$175.93
Day 200 MA	$163.84

Dividends and Splits

Forward Annual Dividend Rate	$3.20
Forward Annual Dividend Yield	1.81%
Trailing Annual Dividend Rate	$3.05
Trailing Annual Dividend Yield	1.72%
Payout Ratio	48.04%
Dividend Date	2025-07-21
Ex Dividend Date	2025-07-07
Last Split Factor
Last Split Date	2005-06-21